| TALFANZA JOHNSON & JOHNSON
1880788 01 Feb 2018 | on 18 Jul 2019 | Class 005 Class 005 Pharmaceutical Products Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases and digital ulcers; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, cerebral palsy and peripheral neurological system diseases; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; anxiolytic medications; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; anti-infective medications; anti-allergic medications; human vaccines | | | TALFREZAN JOHNSON & JOHNSON
1868453 17 Nov 2017 | on 18 Jul 2019 | Class 005 Class 005 Pharmaceutical Products Human pharmaceuticals for the prevention or treatment of auto-immune diseases, cardiovascular diseases, pulmonary hypertension, pulmonary arterial hypertension, gastro-intestinal diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, cerebrovascular diseases and digital ulcers; pharmaceutical preparations for the prevention or treatment of metabolic diseases and disorders, namely diabetes, gout, arthritis and anemia; pharmaceutical preparations for the prevention or treatment of neurological diseases, namely Alzheimer's, Huntington's disease, cerebral palsy and peripheral neurological system diseases; pharmaceutical preparations for the prevention or treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, and schizophrenia; anxiolytic medications; pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases and psoriasis; anti-viral medications; anti-inflammatory medications; anti-pain medications; anti-infective medications; anti-allergic medications; human vaccines | | 
